Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIODESIX INC Director's Dealing 2023

Apr 4, 2023

34472_dirs_2023-04-04_a86f3fe4-a2dc-459a-9889-af8c92469194.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIODESIX INC (BDSX)
CIK: 0001439725
Period of Report: 2023-03-31

Reporting Person: Watts Charles M (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-03-31 Common Stock M 150711 Acquired 202044 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-03-31 Restricted Stock Units $ M 150711 Disposed Common Stock (150711) Direct

Footnotes

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer's common stock.

F2: These RSUs vested in full on March 31, 2023.